Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by Calimmune, Inc.
Sponsor:
Information provided by (Responsible Party):
Calimmune, Inc.
ClinicalTrials.gov Identifier:
NCT01734850
First received: November 19, 2012
Last updated: February 2, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)